Dupuytren Contracture
Conditions
Keywords
Primary Dd disase, MCP joint
Brief summary
Aim: Clinical RCT comparing functional results and recurrence rate following enzymatic treatment vs. needle aponeurotomy. Materials and methods: 30° or more contracture of only one metacarpophalangeal (MCP) joint contracture of one of the three ulnar digits and less than 20° for the adjacent proximal interphalangeal (PIP) joint. Patients with primary disease of the hand. Total of 80 patients needed to detect difference of 13.5°. 1\) Needle aponeurotomy 2) Clostridium Histolyticum treatment. Clinical follow ups 1,4 weeks, 16 weeks and 1,2 and 5 years. Functional outcome scores: URAM, Quick Dash, EQ5D, brief MHQ, VAS pain and VAS patient satisfaction. Total passive extension contracture reduction, recurrence rate and registration of complications.
Detailed description
Open surgery (fascieectomy) has traditionally been considered the gold standard of treatment for Dupytren´s disease (Dd) despite considerable risk of complications. There is an increasing interest in Scandinavia in the treatment of Dd with Clostridium Histolyticum (Xiapex ®, Auxillium). However the enzyme is expensive and long-term effects are not well documented. More studies are needed to analyze both short and long term clinical outcome as well as cost-benefit analysis. The treatment arm of Xiapex in this study follows the recommendation as by the producer. The other treatment of Dd contracture in this study is needle fasiotomy/aponeurotomy. We use multiple perforation technigue with 26 G needle needle, with as little local anesthesia (xylocin w adrenaline) as needed during contionus extension of the finger untill successfully extended. The two procedures leave little scar tissue lessening the challenges posed by the reoperations. Recurrence rate of contracture following different treatments of Dupuytren's disease differs widely in the literature, and the rate is influenced by multiple factors.
Interventions
DRUGXiapex
Injection of collagenase of primary dupytren cord
PROCEDURENeedle aponeurotomy
26 G needle multiple perforation tecqnique with local anesthetic
Sponsors
University Hospital, Akershus
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Primary Dd disease (no earlier treatment for this condition of the hand involved) * Single digit involvement, one of the three ulnar digits * Average norwegian language skills. * MCPJ contracture of 30 degrees or more and less than 20 degree involvement of the adjacent PIPJ * Minimum 18 y.o.
Exclusion criteria
* Involvement of 2 fingers/joints * Earlier treatment for Dd disease of the same hand, affection of addjecent PIPJ of 20 degrees or mor * Pregnancy * Ongoing treatment with platelet inhibitors * Treatment with tetracycline 2 weeks prior to treatment date * Poor norwegian language skills * Participation in other studies 4 weeks prior or after treatment date * Need to treat of both hands
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Total Passive Extension Deficit | 5 years |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| EQ5D (Euroqol 5 Dimensions) | 5 years | — |
| Brief MHQ (Michigan Hand Questionare) | 5 years | — |
| URAM (Unité Rhumatologique des Affections de la Main) | 5 years | — |
| Jamar grip strength | 1,4,26 weeks and one year. | — |
| Quick Dash (Disabilities of the shoulder and Hand) | 5 years | — |
| VAS (Visual analogue sale) satisfaction | 1,4,26 weeks. 1,2 and 5 years | 0 is not satisfied, 10 maximum satisfied |
| Complications | 1,4,weeks One year | AE,SAE,SUSAR |
| Recurrence | 1,4,26 weeks. 1,2 and 5 years | def. 30 degrees of treated MCP joint, or 20 or more degrees of adjecent PIPJ |
| VAS (Visual analogue scale) pain | 1,4,26 weeks and one year | 0 is no pain, 10 maximum pain |
Countries
Norway
Outcome results
None listed